Abstract
Recent advances in genetic testing technology have made chromosome microarray analysis (CMA) a first-tier clinical diagnostic test for Autism Spectrum Disorders (ASDs). Two main types of microarrays are available, single nucleotide polymorphism (SNP) arrays and array comparative genomic hybridization (aCGH), each with its own advantages and disadvantages in ASDs testing. Rare genetic variants, and copy number variants (CNVs) in particular, have been shown to play a major role in ASDs. More than 200 autism susceptibility genes have been identified to date, and complex patterns of inheritance, such as oligogenic heterozygosity, appear to contribute to the etiopathogenesis of ASDs. Incomplete penetrance and variable expressivity represent particular challenges in the interpretation of CMA testing of autistic individuals. This review aims to provide an overview of autism genetics for the practicing physician and gives hands-on advice on how to follow-up on abnormal CMA findings in individuals with neuropsychiatric disorders.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Smalley SL, Asarnow RF, Spence MA. Autism and genetics. Arch Gen Psychiatry. 1988;45:953–61.
• Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–64. A meta-analysis of chromosome microarray testing in individuals with intellectual disability, congenital anomalies, and autism spectrum disorders.
El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am. 2010;33(1):83–105.
Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332–9.
Bayani J, Squire JA. Traditional banding of chromosomes for cytogenetic analysis. Curr Protoc Cell Biol. 2004. Chapter 22:Unit 22.3.
Schaaf CP, Wisznewska J, Beaudet AL. Copy Number and SNP arrays in clinical diagnostics. Annu Rev Genomics Hum Genet. 2011;12:25–51.
National Center for Biotechnology Information (NCBI): NCBI dbSNP build 137 for Human. Available at http://www.ncbi.nlm.nih.gov/mailman/pipermail/dbsnp-announce/2012q2/000123.html. Accessed July 2012.
National Center for Biotechnology Information (NCBI): Human genome assembly information for GRCh37.p9. Available at http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/human/data/index.shtml. Accessed July 2012.
Lubitz RJ, Komaromy M, Crawford B, et al. Development and pilot evaluation of novel genetic educational materials designed for an underserved patient population. Genet Test. 2007;11(3):276–90.
Schaaf CP, Scott DA, Wiszniewska J, Beaudet AL. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet. 2011;377(9765):555–6.
Santangelo AM, de Souza FS, Franchini LF, et al. Ancient exaptation of a CORE-SINE retroposon into a highly conserved mammalian neuronal enhancer of the proopiomelanocortin gene. PloS Genet. 2007;3(10):1813–26.
McClellan J, King MC. Genetic heterogeneity in human disease. Cell. 2010;141:210–7.
Klein RJ, Xu X, Mukherjee S, et al. Successes of genome-wide association studies. Cell. 2010;142:350–1. author reply 353-5.
• Miles JH. Autism spectrum disorders – a genetics review. Genet Med. 2011;13(4):278–94. An excellent, up-to-date review on autism genetics.
Jacquemont ML, Sanlaville D, Redon R, et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet. 2006;43:843–9.
Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316:445–9.
Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82:477–88.
Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569–73.
Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics. 2010;125(4):e727–35.
Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron. 2011;70(5):863–85.
Levy D, Ronemus M, Yamrom B, et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron. 2011;70(5):886–97.
Welberg L. Autism: The importance of getting the dose right. Nat Rev Neurosci. 2011;12(8):429.
Schaaf CP, Sabo A, Sakai Y. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet. 2011;20(17):3366–75.
Leblond CS, Heinrich J, Delorme R. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet. 2012;8(2):e1002521.
Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet. 2010;42(3):203–9.
Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 2009;25(12):528–35.
Sullivan PF, Magnusson C, Reichenberg A, et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry. 2012;2:1–5.
• Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148(6):1223–41. An excellent review on the role of genetics in the etiopathogenesis of neuropsychiatric disorders.
•• Gilman SR, Iossifov I, Levy D, et al. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron. 2011;70(5):898–907. A bioinformatics approach to the complex landscape of autism genetics.
Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010;466(7304):368–72.
Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol. 2009;19(2):231–4.
Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003;302(5646):826–30.
Feng J, Schroer R, Yan J, et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett. 2006;409(1):10–3.
Gauthier J, Siddiqui TJ, Huashan P, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet. 2011;130(4):563–73.
Vaags AK, Lionel AC, Sato D, et al. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet. 2012;90(1):133–41.
Jamain S, Quach H, Betancur C, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet. 2003;34(1):27–9.
Ylisaukko-oja T, Rehnström K, Auranen M, et al. Analysis of four neuroligin genes as candidates for autism. Eur J Hum Genet. 2005;13(12):1285–92.
Sato D, Lionel AC, Leblond CS, et al. SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet. 2012;90(5):879–87.
Berkel S, Marshall CR, Weiss B, et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet. 2010;42(6):489–91.
Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2007;39(1):25–7.
Wang X, McCoy PA, Rodriguiz RM, et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet. 2011;20(15):3093–108.
Chao HT, Zoghbi HY, Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron. 2007;56(1):58–65.
•• Guy J, Gan J, Selfridge J, et al. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007;315(5815):1143–7. A proof-of-concept study that postnatal neurological disorders may be rescuable.
Dölen G, Osterweil E, Rao BS, et al. Correction of fragile X syndrome in mice. Neuron. 2007;56(6):955–62.
Foo JN, Liu JJ, Tan EK. Whole-genome and whole-exome sequencing in neurological diseases. Nat Rev Neurol. 2012 Jul 31.
Lyon GJ, Wang K. Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress. Genome Med. 2012;4(7):58.
Majewski J, Rosenblatt DS. Exome and whole-genome sequencing for gene discovery: the future is now! Hum Mutat. 2012;33(4):591–2.
Bucan M, Abrahams BS, Wang K, et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009;5(6):e1000536.
Brunetti-Pierri N, Berg JS, Scaglia F, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008;40(12):1466–71.
Schaaf CP, Boone PM, Sampath S et al. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. Eur J Hum Genet. 2012 May 23.
Willatt L, Cox J, Barber J, et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet. 2005;77(1):154–60.
Mervis CB, Dida J, Lam E, et al. Duplication of GTF2I results in separation anxiety in mice and humans. Am J Hum Genet. 2012;90(6):1064–70.
Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioral problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet. 2010;47(5):332–41.
Acknowledgments
Dr. Schaaf ’s work is generously supported by the Joan and Stanford Alexander family and the Ting Tsung and Wei Fong Chao Foundation. Dr. Schaaf is the recipient of a Doris Duke Clinical Scientist Development Award.
Disclosure
K.M. Heil: none; C.P. Schaaf is a faculty member of the Department of Molecular and Human Genetics at Baylor College of Medicine, which derives revenue from chromosomal microarray analysis and whole exome sequencing offered in the Medical Genetics Laboratory.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Genetic Disorders
Rights and permissions
About this article
Cite this article
Heil, K.M., Schaaf, C.P. The Genetics of Autism Spectrum Disorders – A Guide for Clinicians. Curr Psychiatry Rep 15, 334 (2013). https://doi.org/10.1007/s11920-012-0334-3
Published:
DOI: https://doi.org/10.1007/s11920-012-0334-3
Keywords
- Autism spectrum disorders
- ASDs
- Autism genetics
- Rare genetic variants
- Copy number variants
- CNVs
- Single-nucleotide polymorphisms arrays
- SNPs
- Chromosome microarrays
- Array comparative genomic hybridization
- aCGH
- Incomplete penetrance
- Variable expressivity
- Oligogenic heterozygosity
- Unclassified variants
- Synaptic plasticity
- Genome sequencing
- Common variant common disease model
- CVCV
- Rare variant common disease model
- RVCD
- Genetic disorders
- Psychiatry